{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T19:40:03Z","timestamp":1750102803408,"version":"3.41.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Deep penetrating nevus (DPN) is a pigmented melanocytic tumor which typically displays a wedge-shaped deep penetrating architecture. Some cases show a coexisting component resembling conventional melanocytic nevus. These morphological attributes are correlated with the acquisition of genomic alterations in the Wnt pathway on a background of underlying activating MAPK pathway mutations. Lesions with features of DPN, but displaying expansile architecture, sheet-like arrangement of cells, cytological atypia, and\/or more than rare mitotic activity have been described as \u201catypical deep penetrating nevus\u201d or \u201cdeep penetrating melanocytoma.\u201d The molecular correlates of these atypical morphological features are not well-established. In this case report, we describe a tumor in an 8-year-old boy with histological features of atypical DPN showing somatic <jats:italic toggle=\"yes\">BRAF<\/jats:italic>\n                           <jats:sup>\n                              V600E\n                           <\/jats:sup>, <jats:italic toggle=\"yes\">beta catenin<\/jats:italic>, and <jats:italic toggle=\"yes\">IDH1<\/jats:italic>\n                           <jats:sup>\n                              R132C\n                           <\/jats:sup> mutations. The combination of abnormalities in MAPK and Wnt pathways with <jats:italic toggle=\"yes\">IDH1<\/jats:italic> mutations seems to be a reproducible feature in a subset of atypical DPNs. Whether this \u201cthree-hit\u201d combination is associated with a significant risk of adverse outcome remains to be established.<\/jats:p>","DOI":"10.1097\/dad.0000000000002198","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T02:00:20Z","timestamp":1649296820000},"page":"607-610","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["An Atypical Deep Penetrating Nevus With Mutations in Beta Catenin, BRAF V600E , and IDH1 R132C in an 8-Year-Old Boy"],"prefix":"10.1097","volume":"44","author":[{"given":"Amanda M.","family":"Ireland","sequence":"first","affiliation":[{"name":"Department of Anatomical Pathology, PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, Nedlands, Perth, Western Australia, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin A.","family":"Wood","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, Nedlands, Perth, Western Australia, Australia;"},{"name":"University of Western Australia, School of Pathology and Laboratory Medicine, Crawley, Perth, Western Australia, Australia; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Whitfield","sequence":"additional","affiliation":[{"name":"Histopathology Department, Sullivan Nicolaides Pathology, Brisbane, Queensland, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benhur","family":"Amanuel","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, Nedlands, Perth, Western Australia, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan T.","family":"Harvey","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, Nedlands, Perth, Western Australia, Australia;"},{"name":"University of Western Australia, School of Pathology and Laboratory Medicine, Crawley, Perth, Western Australia, Australia; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Mesbah Ardakani","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, Nedlands, Perth, Western Australia, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,4,6]]},"reference":[{"key":"R2-20250616","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3389\/fonc.2020.00837","article-title":"Deep penetrating nevus and borderline-deep penetrating nevus: a literature review","volume":"10","author":"Cosgarea","year":"2020","journal-title":"Front Oncol."},{"key":"R3-20250616","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.3390\/cancers13123066","article-title":"NGS-based analysis of atypical deep penetrating nevi","volume":"13","author":"Manca","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R4-20250616","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/PAS.0b013e3181a1ef36","article-title":"Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma","volume":"33","author":"Gerami","year":"2009","journal-title":"Am J Surg Pathol."},{"key":"R5-20250616","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PAS.0b013e31822d5ff8","article-title":"Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe","volume":"36","author":"Gammon","year":"2012","journal-title":"Am J Surg Pathol."},{"key":"R6-20250616","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pathol.2016.11.008","article-title":"Detection of copy number variations in melanocytic lesions utilising array based comparative genomic hybridisation","volume":"49","author":"Mesbah Ardakani","year":"2017","journal-title":"Pathology"},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N Engl J Med."},{"key":"R8-20250616","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1054","article-title":"High frequency of BRAF mutations in nevi","volume":"33","author":"Pollock","year":"2003","journal-title":"Nat Genet."},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/PAS.0b013e3182498be5","article-title":"A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression","volume":"36","author":"Wiesner","year":"2012","journal-title":"Am J Surg Pathol."},{"issue":"4","key":"R10-20250616","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/PAS.0000000000001831","article-title":"Benign and intermediate-grade melanocytic tumors with BRAF mutations and spitzoid morphology: a subset of melanocytic neoplasms distinct from melanoma","volume":"46","author":"Zhao","year":"2022","journal-title":"Am J Surg Pathol."},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41467-017-00758-3","article-title":"Combined activation of MAP kinase pathway and \u03b2-catenin signaling cause deep penetrating nevi","volume":"8","author":"Yeh","year":"2017","journal-title":"Nat Commun."},{"issue":"suppl 1","key":"R12-20250616","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41379-019-0390-x","article-title":"New and evolving concepts of melanocytic nevi and melanocytomas","volume":"33","author":"Yeh","year":"2020","journal-title":"Mod Pathol."},{"key":"R13-20250616","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/modpathol.3880546","article-title":"Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations","volume":"15","author":"Demunter","year":"2002","journal-title":"Mod Pathol."},{"key":"R14-20250616","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/annonc\/mdw013","article-title":"IDH mutations in cancer and progress toward development of targeted therapeutics","volume":"27","author":"Dang","year":"2016","journal-title":"Ann Oncol."},{"key":"R15-20250616","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/his.13707","article-title":"Isocitrate dehydrogenase 1 mutations in melanoma frequently co-occur with NRAS mutations","volume":"73","author":"Linos","year":"2018","journal-title":"Histopathology"},{"key":"R16-20250616","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1097\/PAS.0000000000001500","article-title":"Cutaneous melanocytic tumors with concomitant NRASQ61R and IDH1R132C mutations: a report of 6 cases","volume":"44","author":"Macagno","year":"2020","journal-title":"Am J Surg Pathol."},{"key":"R17-20250616","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ajpath.2010.12.011","article-title":"Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation","volume":"178","author":"Shibata","year":"2011","journal-title":"Am J Pathol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T19:01:40Z","timestamp":1750100500000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,6]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002198","relation":{},"ISSN":["0193-1091"],"issn-type":[{"type":"print","value":"0193-1091"}],"subject":[],"published":{"date-parts":[[2022,4,6]]}}}